Generic Product List For BE Studies

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

 

 
Documents PDF Updated
1st Generic Immediate Release Product List

Download

Mar-17
2nd Generic Immediate Release Product List

Download

Mar-17
3rd Generic Immediate Release Product List

Download

Mar-17
4th Generic Immediate Release Product List

Download

Dec-19
5th Generic Immediate Release Product List

Download

Mar-19

6th Generic Immediate Release Product List

Download

Aug-18
7th Generic Immediate Release Product List

Download

Dec-19
8th Generic Immediate Release Product List

Download

Aug-17

9th Generic Immediate Release Product List

Dec-19
Bioequivalence Requirements According to 1st - 9th List (Active Ingredients arranged in alphabetical orders)

Download

Dec-11
List of Comparator Products For Bioequivalence Studies

Download

Dec-19
List of Comparator Products For Fixed Dose Combination

Download

Dec-19
The Implementation on Antiviral (ARV) Drug

Download

Dec-19
List of Comparator Products in Dosage Forms of Effervescents, Dispersible, Orodispersible, Sublingual, Lozenges, Buccal and Chewable Tablets/Capsules

Download

Dec-19
Product containing combination of amino acid

Download

Apr-14

Comparative Dissolution Profile (CDP) Between Generic Product and Comparator Product with Gastro-Resistance Formulation

Download

Jun-16

3 Ways and 4 Ways Bioequivalence Studies Design

 
 

Aug-09

Buletin Ubat-Ubatan - April 2003 (ARV Drug)

Download

Apr-03
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 26 March 2020, 17:23:39.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language